Thirty-one candidates prove the AI platform makes real drugs
他指出，英矽智能的31个在研候选药物证明其平台能真正做出药物，而不只是软件。
English original
points to Insilico's thirty one developmental candidates as proof its platform delivers real drugs, not just software
在CNBC关于武田交易的采访中
A
亚历克斯·扎沃龙科夫Insilico Medicine · 创始人
报道摘要
Alex Zhavoronkov, Founder, CEO & CBO of Insilico Medicine, says the Takeda deal lets the company scale beyond its own pipeline and become a top global player in AI drug discovery. He breaks down the ...
CNBC